Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/1998
04/30/1998WO1998017802A1 RAINBOW TROUT IL1β; ENCODING NUCLEIC ACID; MATERIALS AND METHODS
04/30/1998WO1998017801A1 METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-α NUCLEIC ACIDS
04/30/1998WO1998017800A1 Novel human cc chemokine larc
04/30/1998WO1998017799A1 Immunotherapy and improved vaccines
04/30/1998WO1998017798A1 Placental-derived prostate growth factors
04/30/1998WO1998017796A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
04/30/1998WO1998017795A1 Nucleic acid encoding ds-cam proteins and products related thereto
04/30/1998WO1998017794A1 Human eosinophil-derived basic protein
04/30/1998WO1998017793A1 Fringe proteins and notch signalling
04/30/1998WO1998017783A1 Improved adenovirus vectors
04/30/1998WO1998017782A1 Method for producing transgenic animal models with modulated phenotype and animals produced therefrom
04/30/1998WO1998017690A1 Receptor specific brain natriuretic peptide (bnp)
04/30/1998WO1998017689A2 Il-12 gene expression and delivery systems and uses
04/30/1998WO1998017688A1 Osteometrin related peptides and nucleic acids and diagnosis and therapies using them
04/30/1998WO1998017687A2 Secreted proteins and polynucleotides encoding them
04/30/1998WO1998017686A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use
04/30/1998WO1998017685A1 Novel lanthionine antibiotic compositions and methods
04/30/1998WO1998017683A2 Human phosphatase inhibitor-1 gene and methods of screening for non-insulin dependent diabetes mellitus
04/30/1998WO1998017682A1 Serine substituted mutants of bcl-xl/bcl-2 associated cell death regulator
04/30/1998WO1998017681A1 Materials and method for the detection and treatment of wegener'sgranulomatosis
04/30/1998WO1998017314A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
04/30/1998WO1998017313A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
04/30/1998WO1998017309A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection
04/30/1998WO1998017304A1 Anti-fibrotic agent assay
04/30/1998WO1998017301A1 Peptides for inhibiting retroviruses
04/30/1998WO1998017300A1 Mucin-mediated immunomodulation
04/30/1998WO1998017242A1 Unique peptides for targeting fibronectin-enriched surfaces and a method for their delivery in the treatment of metastatic cancer
04/30/1998WO1998017107A1 Insecticidally effective peptides isolatable from phidippus spider venom
04/30/1998WO1998011225A3 A novel haemopoietin receptor and genetic sequences encoding same
04/30/1998WO1998008098A3 Assaying D-amino acids in body fluids
04/30/1998WO1998006836A3 Expression system derived from the lipase regulation cascade of pseudomonas alcaligenes
04/30/1998WO1998005685A3 Self-aligning peptides derived from elastin and other fibrous proteins
04/30/1998WO1998004694A3 Secreted proteins and polynucleotides encoding them
04/30/1998WO1998003643A3 Transgenic animals with mutant human APP or A4CT sequences
04/30/1998WO1998002545A3 Compositions and methods for plant pathogen resistance
04/30/1998WO1997048976A3 Method for discovering novel anthelmintic compounds
04/30/1998DE19644567A1 Mikrobielle Herstellung von Substanzen aus dem aromatischen Stoffwechsel / II Microbial production of substances from aromatic metabolism / II
04/30/1998DE19644566A1 Mikrobielle Herstellung von Substanzen aus dem aromatischen Stoffwechsel / I Microbial production of substances from aromatic metabolism / I
04/30/1998DE19644501A1 GABA¶A¶-Rezeptoruntereinheit epsilon-verwandtes Protein GABA¶A¶ receptor epsilon subunit-related protein
04/30/1998DE19644500A1 AAV-DNA mit Helfervirus-Sequenzen AAV DNA having helper virus sequences
04/30/1998CA2751712A1 Immunotherapy and improved vaccines
04/30/1998CA2745736A1 Immunotherapy and improved vaccines
04/30/1998CA2292847A1 Compositions and methods using eukaryotic rad52
04/30/1998CA2272601A1 Peptides for inhibiting retroviruses
04/30/1998CA2271721A1 Mini-e1a genes and gene products
04/30/1998CA2270154A1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
04/30/1998CA2269755A1 Secreted proteins and polynucleotides encoding them
04/30/1998CA2269754A1 Dna vaccines for herpes simplex virus 1 and 2
04/30/1998CA2269711A1 Anti-fibrotic agent assay
04/30/1998CA2269656A1 Receptor specific brain natriuretic peptide (bnp)
04/30/1998CA2269614A1 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
04/30/1998CA2269349A1 Mucin-mediated immunomodulation
04/30/1998CA2269100A1 Methods and compositions for delivery and expression of interferon-.alpha. nucleic acids
04/30/1998CA2269074A1 Immunotherapy and improved vaccines
04/30/1998CA2268949A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus
04/30/1998CA2268751A1 Fringe proteins and notch signalling
04/30/1998CA2268749A1 Structural and functional conservation of the c. elegans clock gene clk-1
04/30/1998CA2268746A1 Placental-derived prostate growth factors
04/30/1998CA2268744A1 Novel lanthionine antibiotic compositions and methods
04/30/1998CA2268742A1 Multi-functional chimeric hematopoietic receptor agonists
04/30/1998CA2268720A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection
04/30/1998CA2268365A1 Il-12 gene expression and delivery systems and uses
04/30/1998CA2268278A1 Methods of reducing the levels of protoporphyrin ix in recombinant hemoglobin preparations
04/30/1998CA2268276A1 Gene expression and delivery systems and uses
04/30/1998CA2268045A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use
04/30/1998CA2268016A1 Human eosinophil-derived basic protein
04/30/1998CA2239766A1 Method for controlling water content of plant
04/29/1998EP0838702A1 Connector for an optical connection
04/29/1998EP0838525A2 Streptococcus pneumoniae polypeptide greA
04/29/1998EP0838524A2 RsbV-1 derived from Staphylococcus
04/29/1998EP0838523A2 RsbW-1 derived from Staphylococcus
04/29/1998EP0838522A2 Coccidiosis poultry vaccine
04/29/1998EP0838474A1 Peptide that inhibits blood triglyceride level rise and blood triglyceride level rise inhibitor containing said peptide as active ingredient
04/29/1998EP0838473A1 Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient
04/29/1998EP0838033A1 GLYCOPROTEIN gp105 ON BL3 HEMATOPOIETIC STEM CELLS
04/29/1998EP0837942A1 Nucleic acid coding for cmp-n-acetyl-neuraminic acid hydroxylase and its use for the production of modified glycoproteins
04/29/1998EP0837940A1 Novel secretion factors for gram-positive microorganisms, genes encoding them and methods of using it
04/29/1998EP0837939A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
04/29/1998EP0837938A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system
04/29/1998EP0837936A1 New immunoregulatory protein lst-1
04/29/1998EP0837935A1 3' utr of the human prohibitin gene
04/29/1998EP0837934A1 Human vascular endothelial growth factor 2
04/29/1998EP0837932A1 Macrophage activating factors derived from cloned vitamin d binding protein
04/29/1998EP0837929A2 Marek's disease virus genes and their use in vaccines for protection against marek's disease
04/29/1998EP0837928A1 Recombinant poxvirus - cytomegalovirus compositions and uses
04/29/1998EP0837927A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
04/29/1998EP0837926A2 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization
04/29/1998EP0837883A2 Method of solubilizing, purifying, and refolding protein
04/29/1998EP0837882A1 Collagen peptide fraction and its uses
04/29/1998EP0837881A2 CONJUGATES OF alpha-MSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG
04/29/1998EP0837880A2 Enamel matrix related polypeptide
04/29/1998EP0837879A1 cDNA CLONES ENCODING HUMAN G PROTEIN $g(g) SUBUNITS
04/29/1998EP0837878A1 Antitumor proteins from rana pipiens oocytes
04/29/1998EP0837876A1 Photoreactive peptide derivatives
04/29/1998EP0837875A2 Inhibitors of farnesyl-protein transferase
04/29/1998EP0837873A1 Novel enhancer sequences for late t cell expressed genes
04/29/1998EP0837869A2 Method for producing synthetic n-linked glycoconjugates
04/29/1998EP0837845A1 Herpes ribonucleotide reductase inhibitors
04/29/1998EP0837694A1 Leptospira membrane proteins
04/29/1998EP0837692A1 Clostridium difficile toxins as mucosal adjuvants
1 ... 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 2413 2414 2415 2416 ... 2916